Stay updated on Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Sign up to get notified when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.

Latest updates to the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page
- Check3 days agoChange DetectedThe page’s software/version footer was updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.1%

- Check10 days agoChange DetectedThe study history shows a new revision label, v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.5.0 was added to the record history, and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page footer revision label changed from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 added to the history; prior notices about funding and operating status (v3.4.1) remain in earlier versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check81 days agoChange DetectedNotice about a lapse in government funding was added, informing users that information may not be up to date and the NIH Clinical Center is open; the page revision history now shows Revision: v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotagliflozin Impact on CV Events in T2D Post HF Clinical Trial page.